Federico A. Colo
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Uncovering Surgical Dynamics and Trends in Early Breast Cancer Stage at Diagnosis: Key Insights From a Two-Decade Argentine Database Analysis.
Journal: JCO global oncology
Published: November 27, 2024
In-Depth Analysis of the Peripheral Immune Profile of HER2+ Breast Cancer Patients on Neoadjuvant Treatment with Chemotherapy Plus Trastuzumab Plus Pertuzumab.
Journal: International journal of molecular sciences
Published: July 02, 2024
The role of modern parameters and their relationship with recurrence risk as assessed by Oncotype DX: real-world evidence.
Journal: Ecancermedicalscience
Published: September 21, 2023
Cyclin-Dependent Kinase 4/6 Inhibitor Outcomes in Patients With Advanced Breast Cancer Carrying Germline Pathogenic Variants in DNA Repair-Related Genes.
Journal: JCO precision oncology
Published: March 02, 2022
Breast Cancer in Young Women Presents With More Aggressive Pathologic Characteristics: Retrospective Analysis From an Argentine National Database.
Journal: JCO global oncology
Published: April 22, 2020
Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients with ACOSOG Z0011 Criteria.
Journal: Breast care (Basel, Switzerland)
Published: February 26, 2019
High neutrophil to lymphocyte ratio and decreased CD69+NK cells represent a phenotype of high risk in early-stage breast cancer patients.
Journal: OncoTargets and therapy
Published: May 31, 2018
High Histologic Grade and High Ki-67 Expression Predict Phenotypic Alterations in Node Metastasis in Primary Breast Cancers.
Journal: Journal of breast cancer
Published: October 15, 2016
Human breast adipose tissue: characterization of factors that change during tumor progression in human breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 07, 2016
Overexpression of CD85j in TNBC patients inhibits Cetuximab-mediated NK-cell ADCC but can be restored with CD85j functional blockade.
Journal: European journal of immunology
Published: November 18, 2014
IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients.
Journal: Breast cancer research and treatment
Published: August 10, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026